Emmanuel J Favaloro Shares Yet Another Paper from The 100th Anniversary of VWD
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”100 years of von Willebrand disease (VWD).
2026 marks the 100th year anniversary of the initial publication of the bleeding disorder ‘pseudo-hemophilia’ that later became known as VWD.
Seminars in Thrombosis and Hemostasis will publish several papers on VWD in 2026.
This is the third one in queue – on VWD therapy – pdVWF vs rVWF concentrate.
Enjoy!”
Read the full article here.
Article: Vonicog Alfa versus Plasma-Derived von Willebrand Factor During Hospitalization: Results of an Observational Retrospective Multicenter Study
Authors: Valérie Horvais, Catherine Ternisien, Julien Denis-Le-Sève, Philippe Beurrier, Marc Fouassier, Antoine Babuty, Nicolas Drillaud, Brigitte Pan-Petesch, Johann Rose, Vincent Cussac, Sophie Bayart, Benoît Guillet, Marc Trossaërt
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 21, 2026, 14:32Moeen Hoseini: The Sex-Specific Associations Between Inflammatory Biomarkers and Vascular Events
-
Jun 21, 2026, 14:23Orton Lungu: Navigating High-Risk Pregnancy in Women Living With Sickle Cell Disease
-
Jun 21, 2026, 14:11Alexandre Kauskot: A Guide to Paris’s Best Riverside Spots for ISTH 2026 Attendees
-
Jun 21, 2026, 14:10Avidesh Panday: Data-Driven Stroke Care Transformation at EWMSC
-
Jun 21, 2026, 13:41Emmanuel J. Favaloro: Honored to Receive the ISLH Wallace H. Coulter Distinguished Lecture Award
-
Jun 21, 2026, 11:50Khalil Ahmad: The Incredible Journey of a Red Blood Cell – A Lifelong Mission of Oxygen Delivery
-
Jun 21, 2026, 08:44Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway
-
Jun 21, 2026, 07:50Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition